Hester Biosciences Reports Mixed Q1 Results with Strong Africa Turnaround Despite India Business Headwinds Aug 04, 2025
Hester Biosciences reported mixed Q1 results. Standalone revenue declined 14% to INR 63.00 crores, with PAT down 7%, due to delayed government immunization programs. Animal Health division saw a 33% decline, while Poultry Healthcare grew 2%. Consolidated PAT grew over 100%, driven by international performance. Hester Africa achieved a significant turnaround, posting INR 5.00 crores profit on INR 17.00 crores revenue. Management remains optimistic about future growth, expecting institutional demand to normalize and awaiting regulatory clearances for new vaccine launches.